dismissal were evaluated by telephone call two weeks after surgery. Postoperative opioid prescribing and use were recorded after conversion to Oral Morphine Equivalents (OME). RESULTS: Overall, 96 women were included, 57 in the initial baseline cohort, and 39 following implementation of the prescribing recommendations. In the initial cohort, 3607/11007 mg (32.8%) of the prescribed OME were consumed. Following implementation of the prescribing recommendations, median OME prescribed decreased from 200 mg OME (IQR 150,225) to 112.5 mg OME (IQR 22.5,112.5; p <0.0001). The total OME prescribed decreased by 45% when compared with the volume that would have been prescribed before implementing the recommendations. The amount of leftover opioids per patient significantly decreased as well (p<0.0001). Pain medication refills increased after the intervention (18% vs 3.5%; p¼0.03), while satisfaction scores were similar in both cohorts (p¼0.87). CONCLUSION: At baseline, overprescribing of opioids following pelvic organ prolapse surgery was common. By utilizing procedure-specific opioid prescribing recommendations we decreased the number of opioids prescribed at hospital dismissal by roughly half. Decreased opioid prescribing did not adversely impact patient satisfaction.
OBJECTIVES: To determine whether, "ICE-T," a novel opioid sparing multimodal postoperative pain regimen is superior to the "Standard" postoperative pain regimen in patients undergoing inpatient vaginal pelvic reconstructive surgery. MATERIALS AND METHODS: This was a multicenter randomized controlled trial of women undergoing vaginal pelvic reconstructive surgery. At the end of surgery patients were randomized to the ICE-T pain regimen or the Standard pain regimen. The ICE-T regimen included around the clock ice packs to the perineum, oral acetaminophen, and intravenous ketorolac with intravenous hydromorphone for breakthrough pain. Patients randomized to the Standard regimen received as needed oral ibuprofen, oral acetaminophen/oxycodone, and intravenous hydromorphone for breakthrough pain. Patients randomized to ICE-T were discharged with oral ketorolac and oral acetaminophen. Patients in the Standard arm were discharged with oral ibuprofen and oral acetaminophen/ oxycodone. Participants received a follow up phone call 96 hours after surgery. The primary outcome was post-operative day one pain the morning after surgery using a visual analog scale (VAS). Secondary outcomes included the validated quality of recovery questionnaire (QoR-40), satisfaction scores, inpatient narcotic consumption, outpatient pain medication consumption, and VAS scores at other time intervals. RESULTS: Thirty patients were randomized to ICE-T and 33 to the Standard therapy. Patient and surgical demographics were similar. The median morning VAS pain score was lower in the ICE-T group (20mm vs. 40mm, P¼0.03). Numerical median pain scores were lower at the 96-hour phone call in the ICE-T group (2 vs. 3, P¼0.04). Patients randomized to the ICE-T regimen received less narcotics (expressed in oral morphine equivalents) from PACU exit to discharge (2.9 vs. 20.4, P<0.001) and received fewer narcotics throughout their entire hospitalization (17.0 vs. 37.6, P<0.001). 54.5% of standard patients compared to 46.7% of ICE-T patients complained of dizziness the morning after surgery (P¼0.03). At 96-hour follow-up, patients in the ICE-T group used 4.9 ketorolac tablets compared to 4.6 acetaminophen/oxycodone tablets in the Standard group (P¼0.81); however, ICE-T patients required more acetaminophen than ibuprofen for patients in the standard arm (10.7 vs. 6.2 tablets, P¼0.012). There were no differences in QoR-40 or satisfaction scores either in the morning after surgery or at 96-hour follow-up. CONCLUSION: The ICE-T multimodal pain regimen offers improved pain control the morning after surgery and 96 hours postoperatively than the Standard regimen with no differences in patient satisfaction and quality of recovery. ICE-T can significantly limit post-operative inpatient narcotic use and eliminate outpatient narcotic use in patients undergoing vaginal pelvic reconstructive surgery.
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Andrey Petrikovets: Nothing to disclose; David Sheyn: Nothing to disclose; Graham Chapman: Nothing to disclose; Helen Sun: Nothing to disclose; Sangeeta T. Mahajan: Nothing to disclose; Robert R. Pollard: Nothing to disclose; Sherif A. El-Nashar: Nothing to disclose; Adonis Hijaz: Nothing to disclose; Jeffrey Mangel: Nothing to disclose. OBJECTIVES: Many surgeons believe that activity restrictions promote postoperative healing and optimizes surgical success resulting in improved disease-specific symptom bother and impact on activities of daily living. However, there is now emerging evidence that early return to physical activity can promote recovery and improve wound healing. A previous randomized trial suggested that liberal postoperative activity instructions was associated with less disease-specific symptom bother than restrictive instructions (Mueller et al). The two primary aims of this study were: 1) to assess the impact of postoperative instructions on disease specific symptom bother and impact on activities of daily living, and 2) to describe the relationship of objective measures of post discharge physical activity on disease specific symptom bother and impact on activities of daily living. MATERIALS AND METHODS: Patients undergoing prolapse repair were randomized to receive liberal or restricted postoperative activity instructions. Objective measures of postdischarge physical activity collected were the Activities Assessment Scale (AAS) and tri-axial accelerometer readings measured at baseline, 2 and 6 weeks after surgery. AAS scores and accelerometer readings were compared between the two groups using separate variance t-tests. Objective measures of physical activity at 2 weeks and 6 weeks after surgery were correlated with the Pelvic Floor Distress Inventory Short Form (PFDI-20) and the Pelvic Floor Impact Questionnaire (PFIQ-7) using Spearman's correlation coefficients. RESULTS: A total of 132 women were recruited between 2/2017-9/ 2018, including 115 patients with completed study data (n¼51 liberal, n¼64 restricted). Postdischarge instructions did not have an impact on symptom bother as measured by PFDI-20 (liberal group 29.96+34, restricted group 33.07+38, p¼0.42), or impact on activities of daily living as measured by PFIQ-7 scores (liberal group 23.33+7.3, restricted group 29.33+6.71, p¼0.86), inconsistent with previous research results. Activity at two weeks as measured by AAS scores negatively correlated with PFDI-20 scores at six weeks (r¼-0.21, p¼0.03), because of changes to the POPDI subscale scores found only in the restrictive group (POPDI-6: r¼-0.32, p¼0.01). There was no correlation between postdischarge activity at 6 weeks and PFDI-20 or PFIQ-7 scores. CONCLUSION: Postoperative instructions did not confer a difference in disease-specific symptom bother, in contrast to previously published results. This lack of difference could be secondary to the fact that patients who were given restricted activity instructions are selfregulating their activity based on how they feel as opposed to the instructions that they are provided. Interventions promoting greater
